Study wrapper · #688
Antistress Action of Melanocortin Derivatives Associated with Correction of Gene Expression Patterns in the Hippocampus of Male Rats Following Acute Stress.
Editor's note
In a rat acute-restraint-stress model, Semax and a related peptide given before stress were associated with attenuated stress-induced behavioral changes, and hippocampal RNA-seq found the peptides corrected many stress-disrupted genes, upregulating genes that stress had lowered and vice versa. About 250 genes were shared between the two peptides, spanning RNA biogenesis, DNA replication and immune and nervous-system function. Linking a behavioral readout to a plausible transcriptomic mechanism is a strength, but it remains a single-lab preclinical study in rats with short post-stress sampling. It fits Semax's broader stress and neuroprotection rodent literature. These are preclinical findings; human data are needed before clinical conclusions can be drawn.
Plain-language abstract
Sudden stress changes both behavior and gene activity in the brain. This rat study tested whether the peptides Semax and a close relative could blunt those effects when given before a stressful restraint procedure. Rats that received a peptide beforehand showed fewer stress-related behavior changes. Examining the hippocampus, a brain region important for memory and stress, the researchers found the peptides reversed many gene changes caused by stress: genes that stress had turned down were turned back up, and vice versa. Roughly 250 genes responded to both peptides, involved in making new molecules, copying DNA, and immune and nervous-system functions. The authors suggest the peptides' anti-stress effect works by restoring normal gene patterns. This is animal and laboratory work exploring mechanism, not a demonstration of benefit in humans.